Novartis AG Borrowing Costs Capitalised
Novartis AG (NVS) reported Borrowing Costs Capitalised of $8.00 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:BorrowingCostsCapitalised · last filed 2026-02-04
| Period end | Borrowing Costs Capitalised 12 month | Borrowing Costs Capitalised 12 month as first filed |
|---|---|---|
| 2025-12-31 | $8.00M 20-F · filed 2026-02-04 | |
| 2024-12-31 | $5.00M 20-F · filed 2026-02-04 | |
| 2023-12-31 | $3.00M 20-F · filed 2026-02-04 | |
| 2022-12-31 | $2.00M 20-F · filed 2025-01-31 | $5.00M 20-F · filed 2023-02-01 |
| 2021-12-31 | $4.00M 20-F/A · filed 2023-05-15 | |
| 2020-12-31 | $2.00M 20-F · filed 2022-02-02 | |
| 2019-12-31 | $4.00M 20-F · filed 2021-01-26 | |
| 2018-12-31 | $6.00M 20-F · filed 2020-01-29 | |
| 2017-12-31 | $9.00M 20-F · filed 2019-01-30 | |
| 2016-12-31 | $9.00M 6-K · filed 2018-01-24 |